Oxiracetam prevents haloperidol-induced passive avoidance impairment in mice.

Abstract

The nootropic drug oxiracetam (50 mg/kg) prevented passive avoidance impairment induced by posttraining administration of haloperidol (0.25 and 0.5 mg/kg). Conversely, oxiracetam did not antagonize either locomotor depression or suppression of active avoidance responses induced by the dopamine receptor blocking agent. The results indicate that prevention of haloperidol-induced retention impairment, by oxiracetam, may be due to a not yet defined protective action, common to other nootropic agents, on different types of experimental amnesias, rather than to a specific interaction with dopaminergic mechanisms.

Statistics

0200400600800'97'99'01'03'05'07'09'11'13'15'17
Citations per Year

78 Citations

Semantic Scholar estimates that this publication has 78 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Castellano1992OxiracetamPH, title={Oxiracetam prevents haloperidol-induced passive avoidance impairment in mice.}, author={Claudio Castellano and Mario Battaglia and Massimo Sansone}, journal={Pharmacology, biochemistry, and behavior}, year={1992}, volume={42 4}, pages={797-801} }